Chuanpu Hu

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Topics

Rheumatoid Arthritis Patients

Top Venues

Journal of pharmacokinetics and pharmacodynamics

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Chuanpu Hu, Anna G Kondic, Amit Roy
Visual predictive check of longitudinal models and dropout. Journal of pharmacokinetics and pharmacodynamics (2024)
Chuanpu Hu, Marion Vetter, An Vermeulen, Daniele Ouellet
Latent variable indirect response modeling of clinical efficacy endpoints with combination therapy: application to guselkumab and golimumab in patients with ulcerative colitis. Journal of pharmacokinetics and pharmacodynamics (2023)
Vincent Lemaire, Chuanpu Hu, Piet H van der Graaf, Steve Chang, Weirong Wang
No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost. Clinical pharmacology and therapeutics (2023)
Chuanpu Hu
Variability and uncertainty: interpretation and usage of pharmacometric simulations and intervals. Journal of pharmacokinetics and pharmacodynamics 49 (5) (2022)
Chuanpu Hu, Honghui Zhou
Improving categorical endpoint longitudinal exposure-response modeling through the joint modeling with a related endpoint. Journal of pharmacokinetics and pharmacodynamics (2021)
Chuanpu Hu, Zhenling Yao, Yang Chen, Bruce Randazzo, Liping Zhang, Zhenhua Xu, Amarnath Sharma, Honghui Zhou
A comprehensive evaluation of exposure-response relationships in clinical trials: application to support guselkumab dose selection for patients with psoriasis. Journal of pharmacokinetics and pharmacodynamics 45 (4) (2018)
Chuanpu Hu, Yan Xu, Yanli Zhuang, Benjamin Hsu, Amarnath Sharma, Zhenhua Xu, Liping Zhang, Honghui Zhou
Joint longitudinal model development: application to exposure-response modeling of ACR and DAS scores in rheumatoid arthritis patients treated with sirukumab. Journal of pharmacokinetics and pharmacodynamics 45 (5) (2018)
Chuanpu Hu, Omoniyi J Adedokun, Liping Zhang, Amarnath Sharma, Honghui Zhou
Modeling near-continuous clinical endpoint as categorical: application to longitudinal exposure-response modeling of Mayo scores for golimumab in patients with ulcerative colitis. Journal of pharmacokinetics and pharmacodynamics 45 (6) (2018)
Chuanpu Hu, Honghui Zhou, Amarnath Sharma
Landmark and longitudinal exposure-response analyses in drug development. Journal of pharmacokinetics and pharmacodynamics 44 (5) (2017)